仙乐健康科技股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 仙乐健康科技股份有限公司 2025 年第三季度报告 | 证券代码：300791 | 证券简称：仙乐健康 | 公告编码：2025-098 | | --- | --- | --- | | 证券代码：123113 | 证券简称：仙乐转债 | | 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同 | | 年初至报告期 | | --- | --- | --- | --- | --- | | | | 期增减 | 年初至报告期末 | 末比上年同期 | | | | | | 增减 ...

| 证券代码：300791 | 证券简称：仙乐健康 公告编码：2025-095 | | --- | --- | | 债券代码：123113 | 债券简称：仙乐转债 | 仙乐健康科技股份有限公司 关于部分董事、高级管理人员减持股份计划期限届满 公司董事杨睿女士保证向本公司提供的信息真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 仙乐健康科技股份有限公司（以下简称"公司"或"仙乐健康"）于 2025 年 7 月 3 日披露了《关于部分董事、高级管理人员减持股份计划的提示性公告》 （公告编码：2025-063），公司董事、副总经理姚壮民先生计划在 2025 年 7 月 25 日至 2025 年 10 月 24 日期间以大宗交易或集中竞价方式减持公司股份不超过 2,019,489 股（约占公司总股本 0.66%），公司董事杨睿女士计划在 2025 年 7 月 25 日至 2025 年 10 月 24 日期间以大宗交易或集中竞价方式减持公司股份不超过 2,481,491 股（约占公司总股本 0.81%）。 公司于近日收到公司董事、副总经理姚 ...

格隆汇10月23日丨仙乐健康(300791.SZ)在互动平台表示，公司业务暂无涉及人造肉领域。 ...

每经AI快讯，有投资者在投资者互动平台提问：请问公司是否有涉及人造肉领域？ 仙乐健康（300791.SZ）10月23日在投资者互动平台表示，公司业务暂无涉及人造肉领域。 （记者 王瀚黎） ...

Core Insights - The food processing sector experienced a slight increase of 0.04% on October 22, with *ST Chuntian leading the gains [1] - The Shanghai Composite Index closed at 3913.76, down 0.07%, while the Shenzhen Component Index closed at 12996.61, down 0.62% [1] Stock Performance - *ST Chuntian (600381) closed at 5.45, up 5.01% with a trading volume of 97,100 shares and a turnover of 52.64 million yuan [1] - Other notable gainers included Jinzi Ham (002515) up 1.91%, Xiwang Food (000639) up 1.27%, and Delisi (002330) up 1.23% [1] - Conversely, Baba Food (605338) saw a decline of 2.72%, while Jiaoda Onl (600530) fell by 2.41% [2] Capital Flow - The food processing sector saw a net outflow of 87.36 million yuan from institutional investors, while retail investors contributed a net inflow of 124 million yuan [2] - The main stocks with significant capital flow included *ST Chuntian, which had a net inflow of 14.16 million yuan from institutional investors [3] - Other stocks like Guangming Meat (600073) and Jindawei (002626) also experienced varying degrees of net inflow and outflow from different investor categories [3]

Investment Rating - The report maintains a recommendation for the liquor sector, indicating a bottoming out phase with potential for recovery in the future [2]. Core Insights - The liquor industry is experiencing a significant decline in sales, with an expected drop of over 20% in overall sales volume. However, there are signs of month-on-month improvement, and the decline is narrowing [5][9]. - Major liquor companies like Moutai and Wuliangye are showing strong recovery in payment collection, with over 80% collection rates, while regional brands are performing adequately [5][9]. - The report emphasizes the importance of focusing on high-quality liquor brands that are likely to recover faster, such as Moutai and Fenjiu, while also highlighting the need to monitor companies undergoing significant changes [6][9]. Summary by Sections 1. Liquor Sector: Q3 Accelerated Decline and Bottoming Out - The liquor sector is facing a 20%+ decline in sales due to external demand shocks, with a gradual improvement expected in the coming months [5][9]. - High-end liquor brands are expected to show resilience, with Moutai projected to achieve a 3% revenue growth in Q3, while Wuliangye is expected to see a 20% revenue decline [10][11]. - The report indicates that companies are adjusting their strategies to reduce channel pressure and improve operational efficiency [9][10]. 2. Consumer Goods Sector: Overall Demand Weakness, Structural Resilience - The consumer goods sector is experiencing overall weak demand, but segments like snacks and beverages are showing higher resilience [17][24]. - The report notes that while the demand for dairy and beer remains stable, the restaurant supply chain is still under pressure [17][24]. - Raw material prices are generally declining, which may provide some cost relief to companies in the sector [24][25]. 3. Investment Recommendations: Focus on Liquor Bottoming Catalysts and Selective Consumer Goods Trends - The report suggests focusing on liquor companies that are at the bottom of their cycles, with Moutai and Fenjiu being primary recommendations [6][9]. - For consumer goods, the report highlights the potential of snack and beverage companies, recommending brands that are well-positioned to benefit from current trends [6][17].

Investment Rating - The report maintains a positive outlook on the health supplement industry, indicating a sustained growth trend in the medium to long term [2][3]. Core Insights - The health supplement market in China is projected to grow from CNY 321.37 billion in 2020 to CNY 415.03 billion by 2024, with a compound annual growth rate (CAGR) of 6.60%, making it the second-largest market globally after the United States [2][3]. - Per capita consumption in China is approximately one-fifth of that in mature markets like Australia, South Korea, and the United States, indicating significant growth potential [3][20]. - The penetration rate among the elderly population (aged 65 and above) in China is only 23.04%, compared to 73.04% in the U.S., suggesting a 2-3 times growth opportunity [3][20]. - The industry is characterized by a diverse range of upstream raw materials, with concentrated production capacity in certain segments, while downstream companies exhibit relatively strong profitability and are accelerating international expansion [3][24]. Summary by Sections Industry Development and Outlook - The health supplement industry in China is expected to maintain a growth trend, with market size projected to reach CNY 447.3 billion by 2029 [16][20]. - The dual-track registration and filing system for health supplements has been implemented, easing industry entry barriers [16][17]. Industry Chain - Upstream: The variety of raw materials includes vitamins, minerals, amino acids, extracts, and probiotics, with some production concentrated among a few key players [24]. - Downstream: Companies often overlap in production and brand marketing, with low sensitivity to cost changes, allowing them to enjoy high added value through premium pricing [3][24][31]. Sales Channels - E-commerce is the primary sales channel, expected to account for 43.9% of sales by 2024, while traditional channels face challenges [4][24]. Key Companies - **Tongrentang**: A leading brand in the VDS segment, focusing on scientific nutrition and maintaining a market share above the industry average [5][32]. - **Jindaiwei**: A company with a full industry chain layout, emphasizing core raw material advantages and international brand localization [9][32]. - **Xianle Health**: A CDMO leader with multi-formulation development capabilities, covering markets in China, the U.S., and Europe [9][32].

Core Viewpoint - The article highlights the controversy surrounding the popular live-streaming host "Dr. Feng from Tsinghua" and a product called "Yangnengjian School-age DHA Algal Oil Lutein Ester Gel Candy," which claims to enhance children's cognitive abilities and protect their eyes from blue light. The product has faced scrutiny for potential false advertising and regulatory violations [1][3][4]. Group 1: Product and Sales Performance - The product "Yangnengjian School-age DHA Algal Oil Lutein Ester Gel Candy" achieved remarkable sales, ranking first on the Douyin platform's best-selling list within a short period [1][3]. - The product is marketed as a dietary supplement rather than a health food or special medical food, which raises questions about its claims and marketing practices [4][6]. Group 2: Regulatory Investigation - The market supervision authority in Jimei District, Xiamen, has initiated an investigation into the product and its marketing practices, citing potential false advertising [4][10]. - The investigation revealed that the live-streaming channel associated with "Dr. Feng" is suspected of engaging in illegal promotional activities, leading to a halt in broadcasts and a requirement for corrective actions [4][10]. Group 3: Legal and Ethical Concerns - Legal experts suggest that the promotional language used by the host may exceed the permissible claims for ordinary food products, potentially misleading consumers about the product's health benefits [7][10]. - The article discusses the broader issue of misleading advertising in live-streaming sales, particularly concerning health-related products, and emphasizes the need for stricter regulations and qualifications for hosts selling such items [9][13].

Investment Rating - The report maintains a "Recommended" rating for the food and beverage industry [1] Core Views - The overall sales of liquor during the recent double festival are weak, with a year-on-year decline of 20%-30%, aligning with previous expectations. High-end brands like Moutai and Wuliangye performed relatively well, while lower-tier brands faced significant pressure [5] - The price stability of liquor during the double festival is noted, with slight increases observed post-festival. The report suggests monitoring price trends as e-commerce promotions begin [5] - The upcoming Sugar and Wine Conference is expected to provide marginal feedback, with the industry showing signs of bottoming out. The report emphasizes the importance of this event for potential recovery opportunities [6][7] Summary by Sections Recent Trends - The food and beverage sector has underperformed the Shanghai Composite Index, with a 0.61% increase compared to the index's 1.80% rise over the past two weeks [14] - The soft drink segment saw the highest increase of 9.98%, while several companies like Zhuangyuan Pasture and Yangyuan Beverage led the gains [14] Key Companies and Earnings Forecast - The report highlights several key companies with their respective earnings per share (EPS) and price-to-earnings (PE) ratios, recommending stocks such as Kweichow Moutai, Wuliangye, and Luzhou Laojiao for investment [25] - The report provides a detailed table of key companies, their stock prices, and projected earnings for 2024, 2025, and 2026, indicating a bullish outlook for several firms [25] Investment Strategy - The report suggests that recent policy changes may improve macroeconomic expectations, potentially enhancing both valuation and performance in the food and beverage sector. The overall valuation remains low, justifying the "Recommended" rating [8][23] - Specific recommendations include high-end liquor brands and popular consumer goods, indicating a diversified investment strategy across different segments of the food and beverage industry [8][23]

Investment Rating - The industry investment rating is "Positive" (maintained) [2] Core Insights - The report highlights structural growth opportunities in new products and channels within the consumer goods sector, particularly in the context of the 25Q3 performance forecast [2] - The performance of various sub-sectors is expected to vary, with specific companies showing significant growth potential due to category advantages and new channel expansions [10][12][14][15][16][19][21][22] Sub-sector Summaries 1.1 Snack Foods - The performance in 25Q3 is expected to be differentiated, with companies like Wanchen Group projected to achieve a revenue growth of 39% and a net profit growth of 382% [2][25] - Emphasis is placed on companies that can leverage category trends and new channel opportunities for sustained growth [10][11] 1.2 Soft Drinks - The energy drink segment is showing improved market conditions, with companies like Dongpeng Beverage expected to see a revenue growth of 31% and a net profit growth of 33% [2][25] - The report suggests focusing on companies with strong brand power and channel capabilities for long-term growth [12][13] 1.3 Dairy Products - The dairy sector is anticipated to experience flat demand in 25Q3, with companies like Yili expected to see only a 2% revenue growth [2][25] - The report indicates that profitability may improve once raw milk prices stabilize [14] 1.4 Tea Drinks - The market is characterized by a leading player, Mixue Group, which is expected to expand its competitive edge through enhanced product offerings [2][15] - The mid-price segment is highlighted as a key growth area, with recommendations for companies like Guming [15] 1.5 Health Supplements - The report notes a trend towards increased concentration in the B-end market, with companies like Xianle Health projected to achieve a revenue growth of 15% [2][25] - The C-end market is advised to focus on high-growth single products [16][17] 1.6 Ready-to-Drink Alcohol - The performance in 25Q3 is expected to be strong, with companies like Bairun expected to see an 8% revenue growth [2][25] - New product launches are anticipated to drive sales growth [18] 1.7 Beer - The impact of the "drinking ban" is expected to be limited, with Qingdao Beer projected to achieve a 2% revenue growth and an 8% net profit growth [2][25] - The report suggests that the beer sector will see stable growth driven by structural upgrades and cost improvements [19][20] 1.8 Condiments - Leading companies like Haitian Flavoring are expected to maintain stable performance, with a revenue growth of 7% [2][25] - The report emphasizes the importance of robust market strategies during periods of flat demand [21] 1.9 Frozen Foods - The sector is facing weak demand, with companies like Anjixin expected to see a 6% revenue growth [2][25] - The report advises monitoring the recovery of the restaurant supply chain for potential investment opportunities [22][23] 1.10 Marinated Products - The focus is on improving store operations as the sector continues to recover from previous challenges [24] Key Company Tracking - The report provides a detailed forecast for various companies across different segments, highlighting expected revenue and net profit growth rates for 25Q3 [25]